Carvedilol

Carvedilol is used to treat heart failure (condition in which the heart cannot pump enough blood to all parts of the body) and high blood pressure. It also is used to treat people who have had a heart attack. Carvedilol is often used in combination with other medications. Carvedilol is in a class of medications called beta-blockers. It works by relaxing blood vessels and slowing heart rate to improve blood flow and decrease blood pressure

High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.

Carvedilol comes as a tablet and an extended-release (long-acting) capsule to take by mouth. The tablet is usually taken twice a day with food. The extended-release capsule is usually taken once a day in the morning with food. Try to take carvedilol at around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take carvedilol exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Swallow the extended-release capsules whole. Do not chew or crush the capsules, and do not divide the beads inside a capsule into more than one dose. If you are unable to swallow the capsules, you may carefully open a capsule and sprinkle all of the beads it contains over a spoonful of cool or room temperature applesauce. Swallow the entire mixture immediately without chewing.

Your doctor will probably start you on a low dose of carvedilol and gradually increase your dose to allow your body to adjust to the medication. Talk to your doctor about how you feel and about any symptoms you experience during this time.

Carvedilol may help to control your condition but will not cure it. Continue taking carvedilol even if you feel well. Do not stop taking carvedilol without talking to your doctor. If you suddenly stop taking carvedilol, you may experience serious heart problems such as severe chest pain, a heart attack, or an irregular heartbeat. Your doctor will probably want to decrease your dose gradually over 1 to 2 weeks. Your doctor will watch you carefully and will probably tell you to avoid physical activity during this time.

This medication may be prescribed for other uses. Ask your doctor or pharmacist for more information.

Before taking carvedilol,

• tell your doctor and pharmacist if you have are allergic to carvedilol, any other medications, or any of the ingredients in carvedilol tablets and extended- release capsules. Ask your pharmacist for a list of the ingredients.

• tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, herbal products, and nutritional supplements you are taking or plan to take. Be sure to mention any of the following: cimetidine; clonidine (Catapres, Kapvay, in Clorpres), cyclosporine (Gengraf, Neoral, Sandimmune); digoxin ( Lanoxin); diltiazem (Cardizem, Cartia, Dilacor, Taztia, Tiazac); epinephrine (Epipen); fluoxetine (Prozac, Sarafem, Selfemra, in Symbyax); insulin; oral medications for diabetes; monoamine oxidase inhibitors (MAOIs) such as isocarboxazid (Marplan), phenelzine (Nardil), tranylcypromine (Parnate), and selegiline (Eldepryl, Emsam, Zelapar); paroxetine (Brisdelle, Paxil); propafenone (Rythmol); quinidine; reserpine; rifampin (Rifadin, Rimactane, in Rifater, in Rifamate); and verapamil (Calan, Covera-HS, Verelan, in Tarka). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

• tell your doctor if you have or have ever had asthma or other breathing problems, a slow or irregular heartbeat, or liver disease. Your doctor may tell you not to take carvedilol.

• tell your doctor if you have or have ever had problems with blood flow in your feet or legs, diabetes or any other condition that causes you to have low blood sugar, hyperthyroidism (condition in which there is too much thyroid hormone in the body), low blood pressure, Prinzmetal's angina (chest pain that comes at rest with no obvious cause), or pheochromocytoma (a tumor that develops on a gland near the kidneys and may cause high blood pressure and fast heartbeat). Also tell your doctor if you have ever had a serious allergic reaction to a food or any other substance.

• tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking carvedilol, call your doctor.

• if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking carvedilol.

• you should know that this medication may make you feel tired, dizzy, or lightheaded, especially when you start taking carvedilol and when your dose is increased. Do not drive a car or operate machinery until you know how this medication affects you. Be especially careful during the first hour after you take the medication.

• do not drink any alcoholic drinks or take any prescription or nonprescription medications that contain alcohol for 2 hours before and 2 hours after you take carvedilol extended-release capsules. Ask your doctor or pharmacist if you do not know if a medication that you plan to take contains alcohol.

• you should know that carvedilol may cause dizziness, lightheadedness, and fainting, especially when you get up too quickly from a lying position. This is more common when you first start taking carvedilol. To avoid this problem, get out of bed slowly, resting your feet on the floor for a few minutes before standing up.

• if you wear contact lenses, your eyes may become dry during your treatment with carvedilol. Tell your doctor if this becomes bothersome.

Unless your doctor tells you otherwise, continue your normal diet.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

• Carvedilol may cause hyperglycemia (high blood sugar). Call your doctor immediately if you have any of the following symptoms of hyperglycemia:

  • extreme thirst

  • frequent urination

  • extreme hunger

  • weakness

  • blurred vision

• Carvedilol may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

  • tiredness

  • weakness

  • lightheadedness

  • dizziness

  • headache

  • diarrhea

  • nausea

  • vomiting

  • vision changes

  • joint pain

  • difficulty falling asleep or staying asleep

  • cough

  • dry eyes

  • numbness, burning, or tingling in the arms or legs

• Some side effects may be serious. If you experience any of the following symptoms, call your doctor immediately:

  • fainting

  • shortness of breath

  • weight gain

  • swelling of the arms, hands, feet, ankles, or lower legs

  • chest pain

  • slow or irregular heartbeat

  • rash

  • hives

  • itching

  • difficulty breathing and swallowing

• Carvedilol may cause other side effects. Tell your doctor if you experience any unusual problems while you are taking this medication.

• If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include:

• slow heartbeat

• dizziness

• fainting

• difficulty breathing

• vomiting

• loss of consciousness

• seizures

Keep all appointments with your doctor and the laboratory. Your doctor may order certain laboratory tests to check your body's response to carvedilol.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug	Interaction
Moxifloxacin	Moxifloxacin The metabolism of Carvedilol can be decreased when combined with Moxifloxacin.
Repaglinide	Repaglinide The therapeutic efficacy of Carvedilol can be increased when used in combination with Repaglinide.
Montelukast	Montelukast The metabolism of Carvedilol can be decreased when combined with Montelukast.
Insulin Glargine (rDNA origin) Injection	Insulin Glargine (rDNA origin) Injection The therapeutic efficacy of Carvedilol can be increased when used in combination with Insulin glargine.
Leflunomide	Leflunomide The serum concentration of Carvedilol can be decreased when it is combined with Leflunomide.
Delavirdine	Delavirdine The metabolism of Carvedilol can be decreased when combined with Delavirdine.
Nevirapine	Nevirapine The metabolism of Carvedilol can be decreased when combined with Nevirapine.
Dolasetron	Dolasetron The metabolism of Carvedilol can be decreased when combined with Dolasetron.
Aminophylline	Aminophylline The metabolism of Aminophylline can be decreased when combined with Carvedilol.
Anagrelide	Anagrelide The metabolism of Carvedilol can be decreased when combined with Anagrelide.
Bisacodyl	Bisacodyl The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Carvedilol.
Calcium Carbonate	Calcium Carbonate The therapeutic efficacy of Carvedilol can be decreased when used in combination with Calcium carbonate.
Candesartan	Candesartan The risk or severity of hyperkalemia can be increased when Carvedilol is combined with Candesartan.
Cilostazol	Cilostazol The metabolism of Cilostazol can be decreased when combined with Carvedilol.
Clopidogrel	Clopidogrel The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Carvedilol.
Erythromycin and Sulfisoxazole	Erythromycin and Sulfisoxazole The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Carvedilol.
Estrogen and Progestin (Oral Contraceptives)	Estrogen and Progestin (Oral Contraceptives) The metabolism of Carvedilol can be decreased when combined with Conjugated estrogens.
Fenofibrate	Fenofibrate The metabolism of Carvedilol can be decreased when combined with Fenofibrate.
Guanfacine	Guanfacine The therapeutic efficacy of Guanfacine can be decreased when used in combination with Carvedilol.
Magnesium Gluconate	Magnesium Gluconate The risk or severity of hypotension can be increased when Carvedilol is combined with Magnesium gluconate.
Magnesium Hydroxide	Magnesium Hydroxide The risk or severity of hypotension can be increased when Carvedilol is combined with Magnesium hydroxide.
Magnesium Oxide	Magnesium Oxide The risk or severity of hypotension can be increased when Carvedilol is combined with Magnesium oxide.
Methylergonovine	Methylergonovine Carvedilol may increase the vasoconstricting activities of Methylergometrine.
Miglitol	Miglitol The therapeutic efficacy of Miglitol can be increased when used in combination with Carvedilol.
Naratriptan	Naratriptan Naratriptan may decrease the antihypertensive activities of Carvedilol.
Olsalazine	Olsalazine Olsalazine may decrease the antihypertensive activities of Carvedilol.
Paregoric	Paregoric The serum concentration of Morphine can be increased when it is combined with Carvedilol.
Penbutolol	Penbutolol The risk or severity of bradycardia can be increased when Carvedilol is combined with Acebutolol.
Polyethylene glycol-electrolyte solution (PEG-ES)	Polyethylene glycol-electrolyte solution (PEG-ES) The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Carvedilol.
Potassium	Potassium Potassium may increase the hyperkalemic activities of Carvedilol.
Psyllium	Psyllium The therapeutic efficacy of Plantago seed can be decreased when used in combination with Carvedilol.
Ranitidine	Ranitidine The metabolism of Carvedilol can be decreased when combined with Ranitidine.
Reserpine	Reserpine The therapeutic efficacy of Carvedilol can be increased when used in combination with Reserpine.
Rizatriptan	Rizatriptan Rizatriptan may decrease the antihypertensive activities of Carvedilol.
Sumatriptan	Sumatriptan Sumatriptan may decrease the antihypertensive activities of Carvedilol.
Tacrolimus	Tacrolimus Carvedilol may increase the immunosuppressive activities of Tacrolimus.
Tizanidine	Tizanidine The therapeutic efficacy of Tizanidine can be decreased when used in combination with Carvedilol.
Zolmitriptan	Zolmitriptan The metabolism of Carvedilol can be decreased when combined with Zolmitriptan.
Famotidine Injection	Famotidine Injection The metabolism of Carvedilol can be decreased when combined with Famotidine.
Fluconazole Injection	Fluconazole Injection The metabolism of Carvedilol can be decreased when combined with Fluconazole.
Hydromorphone Injection	Hydromorphone Injection The metabolism of Carvedilol can be decreased when combined with Hydromorphone.
Interferon Beta-1b Injection	Interferon Beta-1b Injection The metabolism of Carvedilol can be decreased when combined with Interferon beta-1b.
Interferon Gamma-1b Injection	Interferon Gamma-1b Injection The metabolism of Carvedilol can be decreased when combined with Interferon gamma-1b.
Levofloxacin Injection	Levofloxacin Injection The metabolism of Carvedilol can be decreased when combined with Levofloxacin.
Meperidine Injection	Meperidine Injection The metabolism of Carvedilol can be increased when combined with Meperidine.
Metoclopramide Injection	Metoclopramide Injection The metabolism of Carvedilol can be decreased when combined with Metoclopramide.
Metronidazole Injection	Metronidazole Injection The metabolism of Carvedilol can be decreased when combined with Metronidazole.
Morphine Injection	Morphine Injection The serum concentration of Morphine can be increased when it is combined with Carvedilol.
Zidovudine Injection	Zidovudine Injection The metabolism of Carvedilol can be increased when combined with Zidovudine.
Altretamine	Altretamine The therapeutic efficacy of Carvedilol can be decreased when used in combination with Amphetamine.
Cyclosporine	Cyclosporine The serum concentration of Cyclosporine can be increased when it is combined with Carvedilol.
Ondansetron	Ondansetron The metabolism of Carvedilol can be decreased when combined with Ondansetron.
Enoxaparin Injection	Enoxaparin Injection The risk or severity of hyperkalemia can be increased when Carvedilol is combined with Enoxaparin.
Olanzapine	Olanzapine Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Carvedilol.
Alosetron	Alosetron The metabolism of Carvedilol can be decreased when combined with Alosetron.
Dofetilide	Dofetilide Dofetilide may increase the arrhythmogenic activities of Carvedilol.
Entacapone	Entacapone The metabolism of Carvedilol can be decreased when combined with Entacapone.
Eprosartan	Eprosartan The risk or severity of hyperkalemia can be increased when Eprosartan is combined with Carvedilol.
Hydroxychloroquine	Hydroxychloroquine The risk or severity of QTc prolongation can be decreased when Hydroxychloroquine is combined with Carvedilol.
Meloxicam	Meloxicam Meloxicam may decrease the antihypertensive activities of Carvedilol.
Telmisartan	Telmisartan The risk or severity of hyperkalemia can be increased when Telmisartan is combined with Carvedilol.
Anakinra	Anakinra The metabolism of Carvedilol can be increased when combined with Anakinra.
Linezolid	Linezolid Linezolid may increase the hypotensive activities of Carvedilol.
Rivastigmine	Rivastigmine Carvedilol may increase the bradycardic activities of Rivastigmine.
Trimipramine	Trimipramine Trimipramine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Carvedilol.
Etanercept Injection	Etanercept Injection The metabolism of Carvedilol can be increased when combined with Etanercept.
Modafinil	Modafinil The metabolism of Carvedilol can be increased when combined with Modafinil.
Perindopril	Perindopril Perindopril may increase the hypotensive activities of Carvedilol.
Tenofovir	Tenofovir The serum concentration of Tenofovir can be increased when it is combined with Carvedilol.
Choline Magnesium Trisalicylate	Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the antihypertensive activities of Carvedilol.
Sirolimus	Sirolimus Carvedilol may increase the immunosuppressive activities of Sirolimus.
Dutasteride	Dutasteride Dutasteride may decrease the antihypertensive activities of Carvedilol.
Epinephrine Injection	Epinephrine Injection The therapeutic efficacy of Epinephrine can be decreased when used in combination with Carvedilol.
Eplerenone	Eplerenone The risk or severity of hyperkalemia can be increased when Eplerenone is combined with Carvedilol.
Escitalopram	Escitalopram The serum concentration of Carvedilol can be increased when it is combined with Escitalopram.
Olmesartan	Olmesartan The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Carvedilol.
Zonisamide	Zonisamide The risk or severity of bradycardia can be increased when Carvedilol is combined with Zonisamide.
Adalimumab Injection	Adalimumab Injection The metabolism of Carvedilol can be increased when combined with Adalimumab.
Aripiprazole	Aripiprazole Aripiprazole may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Carvedilol.
Atomoxetine	Atomoxetine The metabolism of Carvedilol can be decreased when combined with Atomoxetine.
Dexmethylphenidate	Dexmethylphenidate Dexmethylphenidate may decrease the antihypertensive activities of Carvedilol.
Atazanavir	Atazanavir The metabolism of Carvedilol can be decreased when combined with Atazanavir.
Almotriptan	Almotriptan Almotriptan may decrease the antihypertensive activities of Carvedilol.
Eletriptan	Eletriptan The metabolism of Carvedilol can be decreased when combined with Eletriptan.
Mefloquine	Mefloquine The risk or severity of QTc prolongation can be decreased when Mefloquine is combined with Carvedilol.
Polyethylene Glycol 3350	Polyethylene Glycol 3350 The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Carvedilol.
Rosuvastatin	Rosuvastatin The metabolism of Carvedilol can be decreased when combined with Rosuvastatin.
Vardenafil	Vardenafil The serum concentration of Vardenafil can be increased when it is combined with Carvedilol.
Alfuzosin	Alfuzosin Alfuzosin may increase the hypotensive activities of Carvedilol.
Aprepitant	Aprepitant The metabolism of Carvedilol can be decreased when combined with Aprepitant.
Interferon Beta-1a Subcutaneous Injection	Interferon Beta-1a Subcutaneous Injection The metabolism of Carvedilol can be decreased when combined with Interferon beta-1a.
Memantine	Memantine Memantine may increase the bradycardic activities of Carvedilol.
Tegaserod	Tegaserod The metabolism of Carvedilol can be decreased when combined with Tegaserod.
Tadalafil	Tadalafil The risk or severity of hypotension, dyspepsia, and headache can be increased when Tadalafil is combined with Carvedilol.
Frovatriptan	Frovatriptan The metabolism of Carvedilol can be decreased when combined with Frovatriptan.
Gemifloxacin	Gemifloxacin The metabolism of Carvedilol can be decreased when combined with Gemifloxacin.
Progesterone	Progesterone The metabolism of Carvedilol can be decreased when combined with Progesterone.
Apomorphine Injection	Apomorphine Injection The risk or severity of adverse effects can be increased when Apomorphine is combined with Carvedilol.
Infliximab Injection	Infliximab Injection The metabolism of Carvedilol can be increased when combined with Infliximab.
Oxandrolone	Oxandrolone The metabolism of Carvedilol can be decreased when combined with Oxandrolone.
Protriptyline	Protriptyline Protriptyline may decrease the antihypertensive activities of Carvedilol.
Rifaximin	Rifaximin The serum concentration of Rifaximin can be increased when it is combined with Carvedilol.
Duloxetine	Duloxetine The risk or severity of orthostatic hypotension and syncope can be increased when Carvedilol is combined with Duloxetine.
Trospium	Trospium The metabolism of Carvedilol can be decreased when combined with Trospium.
Bosentan	Bosentan The metabolism of Carvedilol can be increased when combined with Bosentan.
Cinacalcet	Cinacalcet The metabolism of Carvedilol can be decreased when combined with Cinacalcet.
Erlotinib	Erlotinib The metabolism of Carvedilol can be decreased when combined with Erlotinib.
Insulin Aspart (rDNA Origin) Injection	Insulin Aspart (rDNA Origin) Injection The therapeutic efficacy of Carvedilol can be increased when used in combination with Insulin aspart.
Solifenacin	Solifenacin Solifenacin may decrease the antihypertensive activities of Carvedilol.
Voriconazole	Voriconazole The metabolism of Carvedilol can be decreased when combined with Voriconazole.
Dextroamphetamine	Dextroamphetamine The therapeutic efficacy of Carvedilol can be decreased when used in combination with Amphetamine.
Entecavir	Entecavir The metabolism of Carvedilol can be decreased when combined with Entecavir.
Peginterferon Alfa-2a Injection	Peginterferon Alfa-2a Injection The metabolism of Carvedilol can be decreased when combined with Peginterferon alfa-2a.
Peginterferon Alfa-2b (PEG-Intron)	Peginterferon Alfa-2b (PEG-Intron) The serum concentration of Carvedilol can be increased when it is combined with Peginterferon alfa-2b.
Pramlintide Injection	Pramlintide Injection The therapeutic efficacy of Pramlintide can be increased when used in combination with Carvedilol.
Exenatide Injection	Exenatide Injection The therapeutic efficacy of Exenatide can be increased when used in combination with Carvedilol.
Isocarboxazid	Isocarboxazid Isocarboxazid may increase the hypotensive activities of Carvedilol.
Ramelteon	Ramelteon The metabolism of Carvedilol can be decreased when combined with Ramelteon.
Darifenacin	Darifenacin The metabolism of Darifenacin can be decreased when combined with Carvedilol.
Fentanyl	Fentanyl Fentanyl may decrease the antihypertensive activities of Carvedilol.
Pregabalin	Pregabalin Pregabalin may increase the arrhythmogenic activities of Carvedilol.
Deferasirox	Deferasirox The serum concentration of Carvedilol can be increased when it is combined with Deferasirox.
Phenylephrine	Phenylephrine The risk or severity of hypertension can be decreased when Carvedilol is combined with Phenylephrine.
Tipranavir	Tipranavir The metabolism of Tipranavir can be decreased when combined with Carvedilol.
Felbamate	Felbamate The metabolism of Carvedilol can be decreased when combined with Felbamate.
Insulin Detemir (rDNA Origin) Injection	Insulin Detemir (rDNA Origin) Injection The therapeutic efficacy of Carvedilol can be increased when used in combination with Insulin detemir.
Ranolazine	Ranolazine The serum concentration of Ranolazine can be increased when it is combined with Carvedilol.
Abatacept Injection	Abatacept Injection The metabolism of Carvedilol can be increased when combined with Abatacept.
Rasagiline	Rasagiline Rasagiline may increase the hypotensive activities of Carvedilol.
Imatinib	Imatinib The metabolism of Carvedilol can be decreased when combined with Imatinib.
Sitagliptin	Sitagliptin The therapeutic efficacy of Sitagliptin can be increased when used in combination with Carvedilol.
Varenicline	Varenicline The risk or severity of adverse effects can be increased when Carvedilol is combined with Varenicline.
Gefitinib	Gefitinib The metabolism of Carvedilol can be decreased when combined with Gefitinib.
Albuterol	Albuterol The therapeutic efficacy of Salbutamol can be decreased when used in combination with Carvedilol.
Paliperidone	Paliperidone Carvedilol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Paliperidone.
Bortezomib	Bortezomib The serum concentration of Carvedilol can be increased when it is combined with Bortezomib.
Clofarabine Injection	Clofarabine Injection The risk or severity of adverse effects can be increased when Clofarabine is combined with Carvedilol.
Insulin Glulisine (rDNA origin) Injection	Insulin Glulisine (rDNA origin) Injection The therapeutic efficacy of Carvedilol can be increased when used in combination with Insulin glulisine.
Lubiprostone	Lubiprostone The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Carvedilol.
Posaconazole	Posaconazole The serum concentration of Posaconazole can be increased when it is combined with Carvedilol.
Primaquine	Primaquine The metabolism of Carvedilol can be decreased when combined with Primaquine.
Rituximab Injection	Rituximab Injection Carvedilol may increase the hypotensive activities of Rituximab.
Aliskiren	Aliskiren The risk or severity of hyperkalemia can be increased when Carvedilol is combined with Aliskiren.
Darunavir	Darunavir The serum concentration of Carvedilol can be increased when it is combined with Darunavir.
Pemetrexed Injection	Pemetrexed Injection The metabolism of Carvedilol can be decreased when combined with Pemetrexed.
Lisdexamfetamine	Lisdexamfetamine The therapeutic efficacy of Carvedilol can be decreased when used in combination with Lisdexamfetamine.
Nabilone	Nabilone The metabolism of Carvedilol can be decreased when combined with Nabilone.
Sorafenib	Sorafenib The metabolism of Carvedilol can be decreased when combined with Sorafenib.
Sunitinib	Sunitinib The therapeutic efficacy of Sunitinib can be increased when used in combination with Carvedilol.
Dronabinol	Dronabinol The metabolism of Carvedilol can be decreased when combined with Dronabinol.
Dasatinib	Dasatinib The serum concentration of Dasatinib can be increased when it is combined with Carvedilol.
Mexiletine	Mexiletine Mexiletine may increase the arrhythmogenic activities of Carvedilol.
Armodafinil	Armodafinil The metabolism of Carvedilol can be decreased when combined with Armodafinil.
Paclitaxel (with polyoxyethylated castor oil) Injection	Paclitaxel (with polyoxyethylated castor oil) Injection The therapeutic efficacy of Castor oil can be decreased when used in combination with Carvedilol.
Temsirolimus	Temsirolimus The serum concentration of Temsirolimus can be increased when it is combined with Carvedilol.
Nilotinib	Nilotinib The metabolism of Carvedilol can be decreased when combined with Nilotinib.
Toremifene	Toremifene The serum concentration of Toremifene can be increased when it is combined with Carvedilol.
Bexarotene	Bexarotene The metabolism of Carvedilol can be decreased when combined with Bexarotene.
Desmopressin	Desmopressin Desmopressin may decrease the antihypertensive activities of Carvedilol.
Betaine	Betaine Glycine betaine may increase the bradycardic activities of Carvedilol.
Etravirine	Etravirine The metabolism of Carvedilol can be decreased when combined with Etravirine.
Arsenic Trioxide Injection	Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Carvedilol.
Mitoxantrone Injection	Mitoxantrone Injection The metabolism of Carvedilol can be increased when combined with Mitoxantrone.
Desvenlafaxine	Desvenlafaxine The serum concentration of Carvedilol can be increased when it is combined with Desvenlafaxine.
Cevimeline	Cevimeline The risk or severity of adverse effects can be increased when Carvedilol is combined with Cevimeline.
Nebivolol	Nebivolol The risk or severity of bradycardia can be increased when Carvedilol is combined with Nebivolol.
Tretinoin	Tretinoin The risk or severity of adverse effects can be increased when Tretinoin is combined with Carvedilol.
Bendamustine Injection	Bendamustine Injection The serum concentration of Bendamustine can be increased when it is combined with Carvedilol.
Pilocarpine	Pilocarpine The risk or severity of adverse effects can be increased when Carvedilol is combined with Pilocarpine.
Flecainide	Flecainide Carvedilol may increase the arrhythmogenic activities of Flecainide.
Certolizumab Injection	Certolizumab Injection The metabolism of Carvedilol can be increased when combined with Certolizumab pegol.
Praziquantel	Praziquantel The metabolism of Carvedilol can be decreased when combined with Praziquantel.
Rufinamide	Rufinamide The metabolism of Carvedilol can be decreased when combined with Rufinamide.
Silodosin	Silodosin The serum concentration of Silodosin can be increased when it is combined with Carvedilol.
Eltrombopag	Eltrombopag The metabolism of Carvedilol can be decreased when combined with Eltrombopag.
Milnacipran	Milnacipran The serum concentration of Carvedilol can be increased when it is combined with Milnacipran.
Sodium Phosphate	Sodium Phosphate Carvedilol may increase the hyperkalemic activities of Sodium phosphate, monobasic.
Fesoterodine	Fesoterodine The metabolism of Fesoterodine can be decreased when combined with Carvedilol.
Betaxolol	Betaxolol The risk or severity of bradycardia can be increased when Betaxolol is combined with Carvedilol.
Iloperidone	Iloperidone Carvedilol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Iloperidone.
Prasugrel	Prasugrel The metabolism of Prasugrel can be decreased when combined with Carvedilol.
Lacosamide	Lacosamide Carvedilol may increase the bradycardic activities of Lacosamide.
Everolimus	Everolimus The serum concentration of Everolimus can be increased when it is combined with Carvedilol.
Tolvaptan (low blood sodium)	Tolvaptan (low blood sodium) The serum concentration of Tolvaptan can be increased when it is combined with Carvedilol.
Dronedarone	Dronedarone Dronedarone may increase the bradycardic activities of Carvedilol.
Palonosetron Injection	Palonosetron Injection The metabolism of Carvedilol can be decreased when combined with Palonosetron.
Saxagliptin	Saxagliptin The therapeutic efficacy of Saxagliptin can be increased when used in combination with Carvedilol.
Romidepsin Injection	Romidepsin Injection The serum concentration of Romidepsin can be increased when it is combined with Carvedilol.
Tapentadol	Tapentadol The metabolism of Carvedilol can be decreased when combined with Tapentadol.
Topotecan	Topotecan The serum concentration of Topotecan can be increased when it is combined with Carvedilol.
Golimumab Injection	Golimumab Injection The metabolism of Carvedilol can be increased when combined with Golimumab.
Pazopanib	Pazopanib The serum concentration of Pazopanib can be increased when it is combined with Carvedilol.
Asenapine	Asenapine Carvedilol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Asenapine.
Pitavastatin	Pitavastatin The metabolism of Pitavastatin can be decreased when combined with Carvedilol.
Albendazole	Albendazole The metabolism of Carvedilol can be decreased when combined with Albendazole.
Oxymorphone	Oxymorphone The metabolism of Oxymorphone can be decreased when combined with Carvedilol.
Liraglutide Injection	Liraglutide Injection The therapeutic efficacy of Liraglutide can be increased when used in combination with Carvedilol.
Tocilizumab Injection	Tocilizumab Injection The metabolism of Carvedilol can be increased when combined with Tocilizumab.
Fingolimod	Fingolimod Carvedilol may increase the bradycardic activities of Fingolimod.
Cabazitaxel Injection	Cabazitaxel Injection The serum concentration of Cabazitaxel can be increased when it is combined with Carvedilol.
Lurasidone	Lurasidone Carvedilol may increase the hypotensive activities of Lurasidone.
Acetaminophen Injection	Acetaminophen Injection Carvedilol may increase the hepatotoxic activities of Acetaminophen.
Vilazodone	Vilazodone The metabolism of Carvedilol can be decreased when combined with Vilazodone.
Denileukin Diftitox Injection	Denileukin Diftitox Injection The metabolism of Carvedilol can be decreased when combined with Aldesleukin.
Terbutaline Injection	Terbutaline Injection The therapeutic efficacy of Terbutaline can be decreased when used in combination with Carvedilol.
Azilsartan	Azilsartan The risk or severity of hyperkalemia can be increased when Carvedilol is combined with Azilsartan medoxomil.
Linagliptin	Linagliptin The therapeutic efficacy of Linagliptin can be increased when used in combination with Carvedilol.
Rilpivirine	Rilpivirine The metabolism of Carvedilol can be decreased when combined with Rilpivirine.
Telaprevir	Telaprevir The metabolism of Carvedilol can be decreased when combined with Glecaprevir.
Potassium Iodide	Potassium Iodide Potassium Iodide may increase the hyperkalemic activities of Carvedilol.
Cyclophosphamide Injection	Cyclophosphamide Injection The metabolism of Carvedilol can be decreased when combined with Cyclophosphamide.
Abiraterone	Abiraterone The serum concentration of Carvedilol can be increased when it is combined with Abiraterone.
Rivaroxaban	Rivaroxaban The serum concentration of Rivaroxaban can be increased when it is combined with Carvedilol.
Ticagrelor	Ticagrelor The serum concentration of Ticagrelor can be increased when it is combined with Carvedilol.
Brentuximab Vedotin Injection	Brentuximab Vedotin Injection The serum concentration of Brentuximab vedotin can be increased when it is combined with Carvedilol.
Ruxolitinib	Ruxolitinib Ruxolitinib may increase the bradycardic activities of Carvedilol.
Clobazam	Clobazam The metabolism of Clobazam can be decreased when combined with Carvedilol.
Vemurafenib	Vemurafenib The serum concentration of Carvedilol can be increased when it is combined with Vemurafenib.
Vismodegib	Vismodegib The metabolism of Carvedilol can be decreased when combined with Vismodegib.
Axitinib	Axitinib The serum concentration of Axitinib can be increased when it is combined with Carvedilol.
Crizotinib	Crizotinib The serum concentration of Crizotinib can be increased when it is combined with Carvedilol.
Cabergoline	Cabergoline The serum concentration of Cabergoline can be increased when it is combined with Carvedilol.
Ambrisentan	Ambrisentan The serum concentration of Ambrisentan can be increased when it is combined with Carvedilol.
Carfilzomib Injection	Carfilzomib Injection The serum concentration of Carfilzomib can be increased when it is combined with Carvedilol.
Iloprost	Iloprost Iloprost may increase the hypotensive activities of Carvedilol.
Enzalutamide	Enzalutamide The metabolism of Carvedilol can be increased when combined with Enzalutamide.
Mirabegron	Mirabegron The metabolism of Mirabegron can be decreased when combined with Carvedilol.
Regorafenib	Regorafenib Regorafenib may increase the bradycardic activities of Carvedilol.
Bosutinib	Bosutinib The serum concentration of Bosutinib can be increased when it is combined with Carvedilol.
Linaclotide	Linaclotide The therapeutic efficacy of Linaclotide can be decreased when used in combination with Carvedilol.
Teriflunomide	Teriflunomide The serum concentration of Carvedilol can be decreased when it is combined with Teriflunomide.
Lorcaserin	Lorcaserin The therapeutic efficacy of Mecasermin can be increased when used in combination with Carvedilol.
Cabozantinib (thyroid cancer)	Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be decreased when combined with Carvedilol.
Tofacitinib	Tofacitinib Carvedilol may increase the bradycardic activities of Tofacitinib.
Alogliptin	Alogliptin The therapeutic efficacy of Alogliptin can be increased when used in combination with Carvedilol.
Ponatinib	Ponatinib The metabolism of Ponatinib can be decreased when combined with Carvedilol.
Pomalidomide	Pomalidomide The serum concentration of Pomalidomide can be increased when it is combined with Carvedilol.
Ado-trastuzumab Emtansine Injection	Ado-trastuzumab Emtansine Injection The serum concentration of Trastuzumab emtansine can be increased when it is combined with Carvedilol.
Apixaban	Apixaban The serum concentration of Apixaban can be increased when it is combined with Carvedilol.
Canagliflozin	Canagliflozin The therapeutic efficacy of Canagliflozin can be increased when used in combination with Carvedilol.
Methazolamide	Methazolamide The risk or severity of adverse effects can be increased when Methazolamide is combined with Carvedilol.
Dabrafenib	Dabrafenib The serum concentration of Carvedilol can be increased when it is combined with Dabrafenib.
Ospemifene	Ospemifene The metabolism of Ospemifene can be decreased when combined with Carvedilol.
Dolutegravir	Dolutegravir The serum concentration of Dolutegravir can be increased when it is combined with Carvedilol.
Afatinib	Afatinib The serum concentration of Afatinib can be increased when it is combined with Carvedilol.
Levomilnacipran	Levomilnacipran The serum concentration of Carvedilol can be increased when it is combined with Levomilnacipran.
Vortioxetine	Vortioxetine Vortioxetine may decrease the antihypertensive activities of Carvedilol.
Perampanel	Perampanel The metabolism of Perampanel can be decreased when combined with Carvedilol.
Ibrutinib	Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Carvedilol.
Avanafil	Avanafil The risk or severity of hypotension, dyspepsia, and headache can be increased when Avanafil is combined with Carvedilol.
Ketorolac Injection	Ketorolac Injection Ketorolac may decrease the antihypertensive activities of Carvedilol.
Obinutuzumab Injection	Obinutuzumab Injection Carvedilol may increase the hypotensive activities of Obinutuzumab.
Simeprevir	Simeprevir The metabolism of Carvedilol can be decreased when combined with Simeprevir.
Sofosbuvir	Sofosbuvir The serum concentration of Sofosbuvir can be increased when it is combined with Carvedilol.
Dapagliflozin	Dapagliflozin The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Carvedilol.
Apremilast	Apremilast The metabolism of Carvedilol can be increased when combined with Apremilast.
Droxidopa	Droxidopa The therapeutic efficacy of Droxidopa can be decreased when used in combination with Carvedilol.
Ceritinib	Ceritinib Carvedilol may increase the bradycardic activities of Ceritinib.
Siltuximab Injection	Siltuximab Injection The metabolism of Carvedilol can be increased when combined with Siltuximab.
Albiglutide Injection	Albiglutide Injection The therapeutic efficacy of Albiglutide can be increased when used in combination with Carvedilol.
Belinostat Injection	Belinostat Injection The serum concentration of Belinostat can be increased when it is combined with Carvedilol.
Idelalisib	Idelalisib The serum concentration of Idelalisib can be increased when it is combined with Carvedilol.
Testosterone Injection	Testosterone Injection The metabolism of Carvedilol can be decreased when combined with Testosterone.
Oritavancin Injection	Oritavancin Injection The metabolism of Carvedilol can be decreased when combined with Oritavancin.
Empagliflozin	Empagliflozin The therapeutic efficacy of Carvedilol can be increased when used in combination with Empagliflozin.
Dulaglutide Injection	Dulaglutide Injection The therapeutic efficacy of Dulaglutide can be increased when used in combination with Carvedilol.
Edoxaban	Edoxaban The serum concentration of Edoxaban can be increased when it is combined with Carvedilol.
Peginterferon Beta-1a Injection	Peginterferon Beta-1a Injection The metabolism of Carvedilol can be decreased when combined with Peginterferon beta-1a.
Methamphetamine	Methamphetamine The therapeutic efficacy of Carvedilol can be decreased when used in combination with Metamfetamine.
Tasimelteon	Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Carvedilol.
Riociguat	Riociguat Carvedilol may increase the hypotensive activities of Riociguat.
Lanreotide Injection	Lanreotide Injection Carvedilol may increase the bradycardic activities of Lanreotide.
Pirfenidone	Pirfenidone The metabolism of Pirfenidone can be decreased when combined with Carvedilol.
Nintedanib	Nintedanib The serum concentration of Nintedanib can be increased when it is combined with Carvedilol.
Secukinumab Injection	Secukinumab Injection The metabolism of Carvedilol can be increased when combined with Secukinumab.
Risperidone Injection	Risperidone Injection Carvedilol may increase the hypotensive activities of Risperidone.
Insulin Human Inhalation	Insulin Human Inhalation The therapeutic efficacy of Carvedilol can be increased when used in combination with Insulin human.
Lenvatinib	Lenvatinib The serum concentration of Lenvatinib can be increased when it is combined with Carvedilol.
Naloxegol	Naloxegol The serum concentration of Naloxegol can be increased when it is combined with Carvedilol.
Panobinostat	Panobinostat The metabolism of Panobinostat can be decreased when combined with Carvedilol.
Dinutuximab Injection	Dinutuximab Injection The risk or severity of adverse effects can be increased when Dinutuximab is combined with Carvedilol.
Haloperidol Injection	Haloperidol Injection The serum concentration of Carvedilol can be increased when it is combined with Haloperidol.
Ivabradine	Ivabradine Carvedilol may increase the bradycardic activities of Ivabradine.
Amiloride	Amiloride The risk or severity of hyperkalemia can be increased when Amiloride is combined with Carvedilol.
Isavuconazonium Injection	Isavuconazonium Injection The therapeutic efficacy of Isavuconazonium can be increased when used in combination with Carvedilol.
Macitentan	Macitentan Carvedilol may increase the hypotensive activities of Macitentan.
Flibanserin	Flibanserin Flibanserin may decrease the antihypertensive activities of Carvedilol.
Rolapitant	Rolapitant The metabolism of Carvedilol can be decreased when combined with Rolapitant.
Brexpiprazole	Brexpiprazole Carvedilol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Brexpiprazole.
Ziprasidone Injection	Ziprasidone Injection Ziprasidone may increase the antihypertensive activities of Carvedilol.
Cariprazine	Cariprazine Cariprazine may decrease the antihypertensive activities of Carvedilol.
Insulin Degludec (rDNA Origin) Injection	Insulin Degludec (rDNA Origin) Injection The therapeutic efficacy of Carvedilol can be increased when used in combination with Insulin degludec.
Cobimetinib	Cobimetinib The serum concentration of Cobimetinib can be increased when it is combined with Carvedilol.
Trabectedin Injection	Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Carvedilol.
Osimertinib	Osimertinib The serum concentration of Carvedilol can be decreased when it is combined with Osimertinib.
Rifapentine	Rifapentine The metabolism of Carvedilol can be increased when combined with Rifapentine.
Lesinurad	Lesinurad The metabolism of Lesinurad can be decreased when combined with Carvedilol.
Amphotericin B Liposomal Injection	Amphotericin B Liposomal Injection Carvedilol may decrease the nephrotoxic activities of Amphotericin B.
Dexamethasone Injection	Dexamethasone Injection The metabolism of Carvedilol can be increased when combined with Dexamethasone.
Brivaracetam Injection	Brivaracetam Injection The metabolism of Brivaracetam can be decreased when combined with Carvedilol.
Venetoclax	Venetoclax The serum concentration of Venetoclax can be increased when it is combined with Carvedilol.
Cobicistat	Cobicistat The metabolism of Carvedilol can be decreased when combined with Cobicistat.
Midodrine	Midodrine The therapeutic efficacy of Midodrine can be decreased when used in combination with Carvedilol.
Selexipag	Selexipag The serum concentration of Selexipag can be increased when it is combined with Carvedilol.
Obeticholic Acid	Obeticholic Acid The metabolism of Carvedilol can be decreased when combined with Obeticholic acid.
Diphenhydramine Injection	Diphenhydramine Injection The metabolism of Carvedilol can be decreased when combined with Diphenhydramine.
Furosemide Injection	Furosemide Injection Furosemide may increase the hypotensive activities of Carvedilol.
Rucaparib	Rucaparib The metabolism of Carvedilol can be decreased when combined with Rucaparib.
Lixisenatide Injection	Lixisenatide Injection The therapeutic efficacy of Lixisenatide can be increased when used in combination with Carvedilol.
Doxepin (Insomnia)	Doxepin (Insomnia) Carvedilol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Doxepin.
Plecanatide	Plecanatide The therapeutic efficacy of Plecanatide can be decreased when used in combination with Carvedilol.
Deutetrabenazine	Deutetrabenazine The metabolism of Deutetrabenazine can be decreased when combined with Carvedilol.
Valbenazine	Valbenazine The metabolism of Valbenazine can be decreased when combined with Carvedilol.
Safinamide	Safinamide Safinamide may increase the hypotensive activities of Carvedilol.
Midostaurin	Midostaurin The metabolism of Carvedilol can be decreased when combined with Midostaurin.
Enasidenib	Enasidenib The metabolism of Carvedilol can be decreased when combined with Enasidenib.
Inotuzumab Ozogamicin Injection	Inotuzumab Ozogamicin Injection The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Carvedilol.
Copanlisib Injection	Copanlisib Injection The serum concentration of Copanlisib can be increased when it is combined with Carvedilol.
Delafloxacin	Delafloxacin The metabolism of Carvedilol can be increased when combined with Delafloxacin.
Abemaciclib	Abemaciclib The serum concentration of Abemaciclib can be increased when it is combined with Carvedilol.
Betrixaban	Betrixaban The serum concentration of Betrixaban can be increased when it is combined with Carvedilol.
Letermovir	Letermovir The metabolism of Letermovir can be decreased when combined with Carvedilol.
Semaglutide Injection	Semaglutide Injection The therapeutic efficacy of Semaglutide can be increased when used in combination with Carvedilol.
Tetrabenazine	Tetrabenazine The metabolism of Tetrabenazine can be decreased when combined with Carvedilol.
Ertugliflozin	Ertugliflozin The therapeutic efficacy of Carvedilol can be increased when used in combination with Ertugliflozin.
Buprenorphine Injection	Buprenorphine Injection The metabolism of Carvedilol can be decreased when combined with Buprenorphine.
Apalutamide	Apalutamide The metabolism of Carvedilol can be increased when combined with Apalutamide.
Fostamatinib	Fostamatinib The metabolism of Carvedilol can be decreased when combined with Fostamatinib.
Avatrombopag	Avatrombopag The serum concentration of Avatrombopag can be increased when it is combined with Carvedilol.
Baricitinib	Baricitinib The serum concentration of Baricitinib can be increased when it is combined with Carvedilol.
Lofexidine	Lofexidine The therapeutic efficacy of Lofexidine can be decreased when used in combination with Carvedilol.
Eliglustat	Eliglustat The metabolism of Carvedilol can be decreased when combined with Eliglustat.
Encorafenib	Encorafenib The metabolism of Encorafenib can be decreased when combined with Carvedilol.
Binimetinib	Binimetinib The serum concentration of Binimetinib can be increased when it is combined with Carvedilol.
Ivosidenib	Ivosidenib The serum concentration of Ivosidenib can be increased when it is combined with Carvedilol.
Lusutrombopag	Lusutrombopag The serum concentration of Lusutrombopag can be increased when it is combined with Carvedilol.
Elagolix	Elagolix The serum concentration of Elagolix can be increased when it is combined with Carvedilol.
Tafenoquine	Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Carvedilol.
Cannabidiol	Cannabidiol The metabolism of Cannabidiol can be decreased when combined with Carvedilol.
Dacomitinib	Dacomitinib The serum concentration of Carvedilol can be increased when it is combined with Dacomitinib.
Duvelisib	Duvelisib The serum concentration of Duvelisib can be increased when it is combined with Carvedilol.
Omadacycline	Omadacycline The serum concentration of Omadacycline can be increased when it is combined with Carvedilol.
Stiripentol	Stiripentol The metabolism of Carvedilol can be decreased when combined with Stiripentol.
Talazoparib	Talazoparib The serum concentration of Talazoparib can be increased when it is combined with Carvedilol.
Gilteritinib	Gilteritinib The serum concentration of Gilteritinib can be increased when it is combined with Carvedilol.
Glasdegib	Glasdegib The serum concentration of Glasdegib can be increased when it is combined with Carvedilol.
Larotrectinib	Larotrectinib The serum concentration of Larotrectinib can be increased when it is combined with Carvedilol.
Paclitaxel (with albumin) Injection	Paclitaxel (with albumin) Injection The risk or severity of adverse effects can be increased when Paclitaxel is combined with Carvedilol.
Rifamycin	Rifamycin The metabolism of Carvedilol can be increased when combined with Rifamycin.
Prucalopride	Prucalopride The serum concentration of Prucalopride can be increased when it is combined with Carvedilol.
Magnesium Citrate	Magnesium Citrate The risk or severity of hypotension can be increased when Carvedilol is combined with Magnesium citrate.
Emapalumab-lzsg Injection	Emapalumab-lzsg Injection The metabolism of Carvedilol can be increased when combined with Emapalumab.
Siponimod	Siponimod The metabolism of Carvedilol can be decreased when combined with Siponimod.
Acyclovir Ophthalmic	Acyclovir Ophthalmic The metabolism of Carvedilol can be decreased when combined with Acyclovir.
Erdafitinib	Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Carvedilol.
Alpelisib	Alpelisib The serum concentration of Carvedilol can be decreased when it is combined with Alpelisib.
Solriamfetol	Solriamfetol Solriamfetol may decrease the antihypertensive activities of Carvedilol.
Darolutamide	Darolutamide The serum concentration of Darolutamide can be increased when it is combined with Carvedilol.
Triclabendazole	Triclabendazole The metabolism of Carvedilol can be decreased when combined with Triclabendazole.
Pexidartinib	Pexidartinib The metabolism of Carvedilol can be decreased when combined with Pexidartinib.
Istradefylline	Istradefylline The metabolism of Istradefylline can be decreased when combined with Carvedilol.
Pitolisant	Pitolisant The serum concentration of Carvedilol can be decreased when it is combined with Pitolisant.
Fedratinib	Fedratinib The serum concentration of Fedratinib can be increased when it is combined with Carvedilol.
Lefamulin	Lefamulin Carvedilol may decrease the excretion rate of Lefamulin which could result in a higher serum level.
Phenytoin Injection	Phenytoin Injection The metabolism of Phenytoin can be decreased when combined with Carvedilol.
Fosphenytoin Injection	Fosphenytoin Injection The metabolism of Carvedilol can be decreased when combined with Fosphenytoin.
Enfortumab vedotin-ejfv Injection	Enfortumab vedotin-ejfv Injection The serum concentration of Enfortumab vedotin can be increased when it is combined with Carvedilol.
Voxelotor	Voxelotor The metabolism of Voxelotor can be decreased when combined with Carvedilol.
Avapritinib	Avapritinib The metabolism of Avapritinib can be decreased when combined with Carvedilol.
Lasmiditan	Lasmiditan Lasmiditan may increase the bradycardic activities of Carvedilol.
Ubrogepant	Ubrogepant The serum concentration of Ubrogepant can be increased when it is combined with Carvedilol.
Calcium Acetate	Calcium Acetate The therapeutic efficacy of Carvedilol can be decreased when used in combination with Calcium acetate.
Tazemetostat	Tazemetostat The serum concentration of Tazemetostat can be increased when it is combined with Carvedilol.
Cenobamate	Cenobamate The serum concentration of Carvedilol can be decreased when it is combined with Cenobamate.
Selumetinib	Selumetinib The serum concentration of Selumetinib can be increased when it is combined with Carvedilol.
Rimegepant	Rimegepant The serum concentration of Rimegepant can be increased when it is combined with Carvedilol.
Tucatinib	Tucatinib The metabolism of Tucatinib can be decreased when combined with Carvedilol.
Remdesivir Injection	Remdesivir Injection The serum concentration of Remdesivir can be increased when it is combined with Carvedilol.
Ripretinib	Ripretinib The serum concentration of Ripretinib can be increased when it is combined with Carvedilol.
Selpercatinib	Selpercatinib Selpercatinib may decrease the antihypertensive activities of Carvedilol.
Capmatinib	Capmatinib The metabolism of Carvedilol can be decreased when combined with Capmatinib.
Lemborexant	Lemborexant The serum concentration of Lemborexant can be increased when it is combined with Carvedilol.
Fenfluramine	Fenfluramine The metabolism of Carvedilol can be decreased when combined with Fenfluramine.
Fostemsavir	Fostemsavir The serum concentration of Fostemsavir can be increased when it is combined with Carvedilol.
Octreotide	Octreotide The serum concentration of the active metabolites of Carvedilol can be increased when Carvedilol is used in combination with Octreotide.
Belantamab Mafodotin-blmf Injection	Belantamab Mafodotin-blmf Injection The serum concentration of Belantamab mafodotin can be increased when it is combined with Carvedilol.
Pralsetinib	Pralsetinib The serum concentration of Pralsetinib can be increased when it is combined with Carvedilol.
Satralizumab-mwge Injection	Satralizumab-mwge Injection The serum concentration of Carvedilol can be decreased when it is combined with Satralizumab.
Naxitamab-gqgk Injection	Naxitamab-gqgk Injection Naxitamab may decrease the antihypertensive activities of Carvedilol.
Relugolix	Relugolix The serum concentration of Relugolix can be increased when it is combined with Carvedilol.
Progestin-Only (drospirenone) Oral Contraceptives	Progestin-Only (drospirenone) Oral Contraceptives The risk or severity of hyperkalemia can be increased when Carvedilol is combined with Drospirenone.
Viloxazine	Viloxazine The metabolism of Carvedilol can be decreased when combined with Viloxazine.
Theophylline	Theophylline The metabolism of Carvedilol can be decreased when combined with Theophylline.
Fenoprofen	Fenoprofen Fenoprofen may decrease the antihypertensive activities of Carvedilol.
Indomethacin	Indomethacin Indomethacin may decrease the antihypertensive activities of Carvedilol.
Mefenamic Acid	Mefenamic Acid Mefenamic acid may decrease the antihypertensive activities of Carvedilol.
Naproxen	Naproxen Naproxen may decrease the antihypertensive activities of Carvedilol.
Tolmetin	Tolmetin Tolmetin may decrease the antihypertensive activities of Carvedilol.
Sulindac	Sulindac Sulindac may decrease the antihypertensive activities of Carvedilol.
Trazodone	Trazodone Trazodone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Carvedilol.
Hydroxyurea	Hydroxyurea The metabolism of Carvedilol can be decreased when combined with Hydroxyurea.
Floxuridine	Floxuridine The metabolism of Carvedilol can be decreased when combined with Floxuridine.
Phenobarbital	Phenobarbital The metabolism of Phenobarbital can be decreased when combined with Carvedilol.
Primidone	Primidone The metabolism of Carvedilol can be increased when combined with Primidone.
Methsuximide	Methsuximide The risk or severity of bradycardia can be increased when Carvedilol is combined with Methsuximide.
Diethylpropion	Diethylpropion The therapeutic efficacy of Carvedilol can be decreased when used in combination with Diethylpropion.
Chlorpromazine	Chlorpromazine Chlorpromazine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Carvedilol.
Diazepam	Diazepam The metabolism of Carvedilol can be decreased when combined with Diazepam.
Flurazepam	Flurazepam The metabolism of Carvedilol can be decreased when combined with Flurazepam.
Phenoxybenzamine	Phenoxybenzamine Phenoxybenzamine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Carvedilol.
Carmustine	Carmustine The metabolism of Carvedilol can be decreased when combined with Carmustine.
Codeine	Codeine The metabolism of Carvedilol can be decreased when combined with Codeine.
Bromocriptine	Bromocriptine Carvedilol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Bromocriptine.
Metaproterenol	Metaproterenol The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Carvedilol.
Tranylcypromine	Tranylcypromine The metabolism of Carvedilol can be decreased when combined with Tranylcypromine.
Phenelzine	Phenelzine Phenelzine may increase the hypotensive activities of Carvedilol.
Procarbazine	Procarbazine Procarbazine may increase the hypotensive activities of Carvedilol.
Ergoloid Mesylates	Ergoloid Mesylates Carvedilol may increase the vasoconstricting activities of Ergoloid mesylate.
Prochlorperazine	Prochlorperazine The serum concentration of Carvedilol can be increased when it is combined with Prochlorperazine.
Thioridazine	Thioridazine Thioridazine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Carvedilol.
Trifluoperazine	Trifluoperazine Trifluoperazine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Carvedilol.
Dapsone	Dapsone The metabolism of Carvedilol can be decreased when combined with Dapsone.
Sulfadiazine	Sulfadiazine The therapeutic efficacy of Carvedilol can be increased when used in combination with Sulfadiazine.
Oxycodone	Oxycodone The metabolism of Carvedilol can be decreased when combined with Oxycodone.
Methadone	Methadone The metabolism of Carvedilol can be decreased when combined with Methadone.
Oxybutynin	Oxybutynin The metabolism of Carvedilol can be decreased when combined with Oxybutynin.
Benztropine	Benztropine The metabolism of Carvedilol can be decreased when combined with Benzatropine.
Maprotiline	Maprotiline The metabolism of Carvedilol can be decreased when combined with Maprotiline.
Ibuprofen	Ibuprofen Ibuprofen may decrease the antihypertensive activities of Carvedilol.
Orphenadrine	Orphenadrine The metabolism of Carvedilol can be decreased when combined with Orphenadrine.
Perphenazine	Perphenazine The serum concentration of Carvedilol can be increased when it is combined with Perphenazine.
Azathioprine	Azathioprine The metabolism of Carvedilol can be decreased when combined with Azathioprine.
Fluphenazine	Fluphenazine The serum concentration of Carvedilol can be increased when it is combined with Fluphenazine.
Phentermine	Phentermine The therapeutic efficacy of Carvedilol can be decreased when used in combination with Phentermine.
Methylphenidate	Methylphenidate Methylphenidate may decrease the antihypertensive activities of Carvedilol.
Amoxapine	Amoxapine Amoxapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Carvedilol.
Sulfasalazine	Sulfasalazine Sulfasalazine may decrease the antihypertensive activities of Carvedilol.
Doxorubicin	Doxorubicin The serum concentration of Doxorubicin can be increased when it is combined with Carvedilol.
Mechlorethamine	Mechlorethamine Mechlorethamine may increase the bradycardic activities of Carvedilol.
Dactinomycin	Dactinomycin The serum concentration of Dactinomycin can be increased when it is combined with Carvedilol.
Pyridostigmine	Pyridostigmine Pyridostigmine may increase the bradycardic activities of Carvedilol.
Carbamazepine	Carbamazepine The metabolism of Carvedilol can be increased when combined with Carbamazepine.
Methyldopa	Methyldopa The therapeutic efficacy of Methyldopa can be decreased when used in combination with Carvedilol.
Clonidine	Clonidine Clonidine may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Prazosin	Prazosin The risk or severity of hypotension can be increased when Prazosin is combined with Carvedilol.
Hydralazine	Hydralazine Carvedilol may increase the hypotensive activities of Hydralazine.
Cimetidine	Cimetidine The serum concentration of Carvedilol can be increased when it is combined with Cimetidine.
Warfarin	Warfarin The metabolism of Carvedilol can be decreased when combined with Warfarin.
Clonazepam	Clonazepam The metabolism of Carvedilol can be decreased when combined with Clonazepam.
Loperamide	Loperamide The risk or severity of bradycardia can be increased when Carvedilol is combined with Loperamide.
Promethazine	Promethazine The serum concentration of Carvedilol can be increased when it is combined with Promethazine.
Meclofenamate	Meclofenamate Meclofenamic acid may decrease the antihypertensive activities of Carvedilol.
Nitrofurantoin	Nitrofurantoin The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Carvedilol.
Griseofulvin	Griseofulvin The metabolism of Carvedilol can be increased when combined with Griseofulvin.
Digoxin	Digoxin The serum concentration of Digoxin can be increased when it is combined with Carvedilol.
Chloroquine	Chloroquine The metabolism of Carvedilol can be decreased when combined with Chloroquine.
Quinine	Quinine The metabolism of Quinine can be decreased when combined with Carvedilol.
Ethosuximide	Ethosuximide The risk or severity of bradycardia can be increased when Ethosuximide is combined with Carvedilol.
Triamterene	Triamterene The metabolism of Carvedilol can be decreased when combined with Triamterene.
Lactulose	Lactulose The therapeutic efficacy of Lactulose can be decreased when used in combination with Carvedilol.
Sulfinpyrazone	Sulfinpyrazone The metabolism of Carvedilol can be decreased when combined with Sulfinpyrazone.
Chlorothiazide	Chlorothiazide The therapeutic efficacy of Carvedilol can be increased when used in combination with Chlorothiazide.
Chlorthalidone	Chlorthalidone Chlorthalidone may increase the hypotensive activities of Carvedilol.
Metolazone	Metolazone Metolazone may increase the hypotensive activities of Carvedilol.
Isosorbide	Isosorbide Carvedilol may increase the vasodilatory activities of Isosorbide.
Secobarbital	Secobarbital The serum concentration of Carvedilol can be decreased when it is combined with Secobarbital.
Desipramine	Desipramine The metabolism of Desipramine can be decreased when combined with Carvedilol.
Amitriptyline	Amitriptyline Amitriptyline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Carvedilol.
Imipramine	Imipramine Carvedilol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Imipramine.
Probenecid	Probenecid The metabolism of Carvedilol can be decreased when combined with Probenecid.
Quinidine	Quinidine Carvedilol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.
Procainamide	Procainamide Carvedilol may increase the arrhythmogenic activities of Procainamide.
Isoniazid	Isoniazid The metabolism of Carvedilol can be decreased when combined with Isoniazid.
Rifampin	Rifampin The metabolism of Carvedilol can be increased when combined with Rifampicin.
Disopyramide	Disopyramide Disopyramide may increase the bradycardic activities of Carvedilol.
Valproic Acid	Valproic Acid The metabolism of Carvedilol can be decreased when combined with Valproic acid.
Tamoxifen	Tamoxifen The metabolism of Carvedilol can be decreased when combined with Tamoxifen.
Butabarbital	Butabarbital Butabarbital may increase the hypotensive activities of Carvedilol.
Levothyroxine	Levothyroxine The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Carvedilol.
Liothyronine	Liothyronine The therapeutic efficacy of Liothyronine can be decreased when used in combination with Carvedilol.
Methimazole	Methimazole The excretion of Carvedilol can be decreased when combined with Methimazole.
Chlorpropamide	Chlorpropamide The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Carvedilol.
Glucagon Injection	Glucagon Injection The therapeutic efficacy of Carvedilol can be decreased when used in combination with Glucagon.
Tolbutamide	Tolbutamide The therapeutic efficacy of Tolbutamide can be increased when used in combination with Carvedilol.
Tolazamide	Tolazamide The therapeutic efficacy of Tolazamide can be increased when used in combination with Carvedilol.
Dextromethorphan	Dextromethorphan The metabolism of Carvedilol can be decreased when combined with Dextromethorphan.
Cyclobenzaprine	Cyclobenzaprine The metabolism of Carvedilol can be decreased when combined with Cyclobenzaprine.
Niacin	Niacin The metabolism of Carvedilol can be decreased when combined with Niacin.
Baclofen	Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Carvedilol.
Clemastine	Clemastine The metabolism of Carvedilol can be decreased when combined with Clemastine.
Chlorpheniramine	Chlorpheniramine The metabolism of Carvedilol can be decreased when combined with Chlorpheniramine.
Meclizine	Meclizine The metabolism of Carvedilol can be decreased when combined with Meclizine.
Methyclothiazide	Methyclothiazide The therapeutic efficacy of Carvedilol can be increased when used in combination with Methyclothiazide.
Hydrochlorothiazide	Hydrochlorothiazide The therapeutic efficacy of Carvedilol can be increased when used in combination with Hydrochlorothiazide.
Dantrolene	Dantrolene The risk or severity of hyperkalemia can be increased when Dantrolene is combined with Carvedilol.
Chlorzoxazone	Chlorzoxazone The metabolism of Carvedilol can be decreased when combined with Chlorzoxazone.
Disulfiram	Disulfiram The metabolism of Carvedilol can be decreased when combined with Disulfiram.
Propranolol (Cardiovascular)	Propranolol (Cardiovascular) The risk or severity of bradycardia can be increased when Carvedilol is combined with Propranolol.
Minoxidil	Minoxidil Minoxidil may increase the hypotensive activities of Carvedilol.
Pseudoephedrine	Pseudoephedrine The therapeutic efficacy of Carvedilol can be decreased when used in combination with Pseudoephedrine.
Nortriptyline	Nortriptyline Nortriptyline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Carvedilol.
Spironolactone	Spironolactone The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Carvedilol.
Amphotericin B Injection	Amphotericin B Injection Carvedilol may decrease the nephrotoxic activities of Amphotericin B.
Mercaptopurine	Mercaptopurine The risk or severity of adverse effects can be increased when Carvedilol is combined with Mercaptopurine.
Nadolol	Nadolol The risk or severity of bradycardia can be increased when Carvedilol is combined with Nadolol.
Clomiphene	Clomiphene The serum concentration of Clomifene can be increased when it is combined with Carvedilol.
Papaverine	Papaverine The risk or severity of adverse effects can be increased when Papaverine is combined with Carvedilol.
Fluorouracil Injection	Fluorouracil Injection The metabolism of Carvedilol can be decreased when combined with Fluorouracil.
Colchicine	Colchicine The serum concentration of Colchicine can be increased when it is combined with Carvedilol.
Dacarbazine	Dacarbazine The metabolism of Carvedilol can be decreased when combined with Dacarbazine.
Ketoconazole	Ketoconazole The metabolism of Carvedilol can be decreased when combined with Ketoconazole.
Thiotepa Injection	Thiotepa Injection Thiotepa may increase the bradycardic activities of Carvedilol.
Vincristine Injection	Vincristine Injection The excretion of Vincristine can be decreased when combined with Carvedilol.
Captopril	Captopril The risk or severity of hyperkalemia can be increased when Carvedilol is combined with Captopril.
Dipyridamole	Dipyridamole Dipyridamole may increase the bradycardic activities of Carvedilol.
Isoxsuprine	Isoxsuprine The therapeutic efficacy of Isoxsuprine can be decreased when used in combination with Carvedilol.
Vinblastine	Vinblastine The serum concentration of Vinblastine can be increased when it is combined with Carvedilol.
Bethanechol	Bethanechol The risk or severity of adverse effects can be increased when Carvedilol is combined with Bethanechol.
Ethacrynic Acid	Ethacrynic Acid The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Carvedilol.
Metoprolol	Metoprolol The metabolism of Carvedilol can be decreased when combined with Metoprolol.
Hydroxyzine	Hydroxyzine The metabolism of Carvedilol can be decreased when combined with Hydroxyzine.
Thiothixene	Thiothixene The metabolism of Thiothixene can be decreased when combined with Carvedilol.
Aspirin	Aspirin Acetylsalicylic acid may decrease the antihypertensive activities of Carvedilol.
Salsalate	Salsalate Salsalate may decrease the antihypertensive activities of Carvedilol.
Hyoscyamine	Hyoscyamine Hyoscyamine may increase the arrhythmogenic activities of Carvedilol.
Trimethoprim	Trimethoprim The risk or severity of hyperkalemia can be increased when Trimethoprim is combined with Carvedilol.
Diltiazem	Diltiazem The risk or severity of bradycardia can be increased when Carvedilol is combined with Diltiazem.
Nifedipine	Nifedipine The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Carvedilol.
Timolol	Timolol The risk or severity of adverse effects can be increased when Timolol is combined with Carvedilol.
Verapamil	Verapamil The risk or severity of adverse effects can be increased when Verapamil is combined with Carvedilol.
Atenolol	Atenolol The risk or severity of bradycardia can be increased when Atenolol is combined with Carvedilol.
Pindolol	Pindolol The risk or severity of bradycardia can be increased when Pindolol is combined with Carvedilol.
Cisplatin Injection	Cisplatin Injection The metabolism of Carvedilol can be decreased when combined with Cisplatin.
Diflunisal	Diflunisal Diflunisal may decrease the antihypertensive activities of Carvedilol.
Piroxicam	Piroxicam Piroxicam may decrease the antihypertensive activities of Carvedilol.
Bumetanide	Bumetanide The risk or severity of adverse effects can be increased when Bumetanide is combined with Carvedilol.
Streptozocin	Streptozocin The metabolism of Carvedilol can be increased when combined with Streptozocin.
Etoposide	Etoposide The serum concentration of Etoposide can be increased when it is combined with Carvedilol.
Glyburide	Glyburide The therapeutic efficacy of Glyburide can be increased when used in combination with Carvedilol.
Glipizide	Glipizide The therapeutic efficacy of Glipizide can be increased when used in combination with Carvedilol.
Indapamide	Indapamide The therapeutic efficacy of Carvedilol can be increased when used in combination with Indapamide.
Nafcillin Injection	Nafcillin Injection The therapeutic efficacy of Carvedilol can be decreased when used in combination with Nafcillin.
Pentoxifylline	Pentoxifylline Pentoxifylline may increase the hypotensive activities of Carvedilol.
Pentamidine Injection	Pentamidine Injection The therapeutic efficacy of Carvedilol can be increased when used in combination with Pentamidine.
Labetalol	Labetalol Labetalol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Carvedilol.
Gemfibrozil	Gemfibrozil The metabolism of Carvedilol can be decreased when combined with Gemfibrozil.
Guanabenz	Guanabenz The therapeutic efficacy of Guanabenz can be decreased when used in combination with Carvedilol.
Ketoprofen	Ketoprofen Ketoprofen may decrease the antihypertensive activities of Carvedilol.
Pimozide	Pimozide The metabolism of Carvedilol can be decreased when combined with Pimozide.
Enalapril	Enalapril The risk or severity of hyperkalemia can be increased when Enalapril is combined with Carvedilol.
Flurbiprofen	Flurbiprofen Flurbiprofen may decrease the antihypertensive activities of Carvedilol.
Amiodarone	Amiodarone The therapeutic efficacy of Carvedilol can be increased when used in combination with Amiodarone.
Buspirone	Buspirone Buspirone may decrease the antihypertensive activities of Carvedilol.
Lovastatin	Lovastatin The metabolism of Carvedilol can be decreased when combined with Lovastatin.
Ciprofloxacin	Ciprofloxacin The metabolism of Carvedilol can be decreased when combined with Ciprofloxacin.
Mesalamine	Mesalamine Mesalazine may decrease the antihypertensive activities of Carvedilol.
Diclofenac	Diclofenac Diclofenac may decrease the antihypertensive activities of Carvedilol.
Fluoxetine	Fluoxetine The serum concentration of Carvedilol can be increased when it is combined with Fluoxetine.
Nimodipine	Nimodipine The risk or severity of bradycardia can be increased when Carvedilol is combined with Nimodipine.
Interferon Alfa-2b Injection	Interferon Alfa-2b Injection The metabolism of Carvedilol can be decreased when combined with Interferon alfa-2b.
Clozapine	Clozapine Clozapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Carvedilol.
Idarubicin	Idarubicin The metabolism of Idarubicin can be decreased when combined with Carvedilol.
Ofloxacin	Ofloxacin The metabolism of Carvedilol can be decreased when combined with Ofloxacin.
Clarithromycin	Clarithromycin The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Carvedilol.
Benazepril	Benazepril The risk or severity of hyperkalemia can be increased when Benazepril is combined with Carvedilol.
Etodolac	Etodolac Etodolac may decrease the antihypertensive activities of Carvedilol.
Felodipine	Felodipine The risk or severity of bradycardia can be increased when Felodipine is combined with Carvedilol.
Fosinopril	Fosinopril The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Carvedilol.
Nabumetone	Nabumetone Nabumetone may decrease the antihypertensive activities of Carvedilol.
Pravastatin	Pravastatin The serum concentration of Pravastatin can be increased when it is combined with Carvedilol.
Quinapril	Quinapril The risk or severity of hyperkalemia can be increased when Quinapril is combined with Carvedilol.
Ramipril	Ramipril Ramipril may increase the hypotensive activities of Carvedilol.
Simvastatin	Simvastatin The metabolism of Simvastatin can be decreased when combined with Carvedilol.
Amlodipine	Amlodipine The risk or severity of bradycardia can be increased when Carvedilol is combined with Amlodipine.
Teniposide Injection	Teniposide Injection The metabolism of Carvedilol can be decreased when combined with Teniposide.
Itraconazole	Itraconazole The metabolism of Carvedilol can be decreased when combined with Itraconazole.
Lisinopril	Lisinopril The risk or severity of hyperkalemia can be increased when Lisinopril is combined with Carvedilol.
Oxaprozin	Oxaprozin Oxaprozin may decrease the antihypertensive activities of Carvedilol.
Atovaquone	Atovaquone The metabolism of Carvedilol can be decreased when combined with Atovaquone.
Sotalol	Sotalol The risk or severity of bradycardia can be increased when Carvedilol is combined with Sotalol.
Bisoprolol	Bisoprolol The risk or severity of adverse effects can be increased when Bisoprolol is combined with Carvedilol.
Zolpidem	Zolpidem The metabolism of Carvedilol can be decreased when combined with Zolpidem.
Doxazosin	Doxazosin Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Carvedilol.
Terazosin	Terazosin Carvedilol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Terazosin.
Isradipine	Isradipine The risk or severity of bradycardia can be increased when Carvedilol is combined with Isradipine.
Omeprazole	Omeprazole The metabolism of Carvedilol can be increased when combined with Omeprazole.
Cisapride	Cisapride The metabolism of Carvedilol can be decreased when combined with Cisapride.
Fluvastatin	Fluvastatin The metabolism of Carvedilol can be decreased when combined with Fluvastatin.
Venlafaxine	Venlafaxine The metabolism of Carvedilol can be decreased when combined with Venlafaxine.
Nizatidine	Nizatidine Nizatidine may increase the bradycardic activities of Carvedilol.
Fluvoxamine	Fluvoxamine The metabolism of Carvedilol can be decreased when combined with Fluvoxamine.
Nefazodone	Nefazodone Carvedilol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Nefazodone.
Lamotrigine	Lamotrigine The risk or severity of bradycardia can be increased when Lamotrigine is combined with Carvedilol.
Losartan	Losartan Carvedilol may increase the arrhythmogenic activities of Losartan.
Tramadol	Tramadol The metabolism of Carvedilol can be decreased when combined with Tramadol.
Vinorelbine Injection	Vinorelbine Injection The metabolism of Carvedilol can be decreased when combined with Vinorelbine.
Moexipril	Moexipril The risk or severity of hyperkalemia can be increased when Moexipril is combined with Carvedilol.
Lansoprazole	Lansoprazole The metabolism of Carvedilol can be decreased when combined with Lansoprazole.
Ifosfamide Injection	Ifosfamide Injection The metabolism of Ifosfamide can be decreased when combined with Carvedilol.
Nicardipine	Nicardipine Nicardipine may increase the hypotensive activities of Carvedilol.
Bupropion	Bupropion The metabolism of Carvedilol can be decreased when combined with Bupropion.
Ticlopidine	Ticlopidine The metabolism of Carvedilol can be decreased when combined with Ticlopidine.
Saquinavir	Saquinavir The serum concentration of Saquinavir can be increased when it is combined with Carvedilol.
Metformin	Metformin The therapeutic efficacy of Metformin can be increased when used in combination with Carvedilol.
Dalteparin Injection	Dalteparin Injection The risk or severity of hyperkalemia can be increased when Carvedilol is combined with Dalteparin.
Nisoldipine	Nisoldipine The risk or severity of bradycardia can be increased when Nisoldipine is combined with Carvedilol.
Riluzole	Riluzole The metabolism of Carvedilol can be decreased when combined with Riluzole.
Amifostine Injection	Amifostine Injection Carvedilol may increase the hypotensive activities of Amifostine.
Acarbose	Acarbose The therapeutic efficacy of Acarbose can be increased when used in combination with Carvedilol.
Glimepiride	Glimepiride Carvedilol may increase the arrhythmogenic activities of Glimepiride.
Gemcitabine Injection	Gemcitabine Injection The serum concentration of Gemcitabine can be increased when it is combined with Carvedilol.
Indinavir	Indinavir The metabolism of Carvedilol can be decreased when combined with Indinavir.
Ritonavir	Ritonavir The serum concentration of Carvedilol can be increased when it is combined with Ritonavir.
Clomipramine	Clomipramine The metabolism of Carvedilol can be decreased when combined with Clomipramine.
Zafirlukast	Zafirlukast The metabolism of Carvedilol can be decreased when combined with Zafirlukast.
Mirtazapine	Mirtazapine The metabolism of Carvedilol can be decreased when combined with Mirtazapine.
Trandolapril	Trandolapril The risk or severity of hyperkalemia can be increased when Trandolapril is combined with Carvedilol.
Zileuton	Zileuton The metabolism of Carvedilol can be decreased when combined with Zileuton.
Valsartan	Valsartan The metabolism of Carvedilol can be decreased when combined with Valsartan.
Insulin Lispro Injection	Insulin Lispro Injection The therapeutic efficacy of Carvedilol can be increased when used in combination with Insulin lispro.
Pramipexole	Pramipexole The risk or severity of adverse effects can be increased when Pramipexole is combined with Carvedilol.
Donepezil	Donepezil Donepezil may increase the bradycardic activities of Carvedilol.
Nelfinavir	Nelfinavir The metabolism of Carvedilol can be decreased when combined with Nelfinavir.
Fexofenadine	Fexofenadine The serum concentration of Fexofenadine can be increased when it is combined with Carvedilol.
Nilutamide	Nilutamide The metabolism of Carvedilol can be decreased when combined with Nilutamide.
Flutamide	Flutamide The metabolism of Carvedilol can be decreased when combined with Flutamide.
Selegiline	Selegiline Selegiline may increase the hypotensive activities of Carvedilol.
Bicalutamide	Bicalutamide The metabolism of Carvedilol can be decreased when combined with Bicalutamide.
Sertraline	Sertraline The metabolism of Carvedilol can be decreased when combined with Sertraline.
Propafenone	Propafenone The risk or severity of adverse effects can be increased when Propafenone is combined with Carvedilol.
Irbesartan	Irbesartan The risk or severity of hyperkalemia can be increased when Irbesartan is combined with Carvedilol.
Tamsulosin	Tamsulosin Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Carvedilol.
Ropinirole	Ropinirole The risk or severity of adverse effects can be increased when Ropinirole is combined with Carvedilol.
Finasteride	Finasteride Finasteride may decrease the antihypertensive activities of Carvedilol.
Quetiapine	Quetiapine Carvedilol may increase the hypotensive activities of Quetiapine.
Paroxetine	Paroxetine The metabolism of Carvedilol can be decreased when combined with Paroxetine.
Tolcapone	Tolcapone The metabolism of Carvedilol can be decreased when combined with Tolcapone.
Citalopram	Citalopram The metabolism of Carvedilol can be decreased when combined with Citalopram.
Capecitabine	Capecitabine The metabolism of Carvedilol can be decreased when combined with Capecitabine.
Efavirenz	Efavirenz The serum concentration of Carvedilol can be decreased when it is combined with Efavirenz.
Sildenafil	Sildenafil The risk or severity of hypotension can be increased when Carvedilol is combined with Sildenafil.
Pioglitazone	Pioglitazone The therapeutic efficacy of Carvedilol can be increased when used in combination with Pioglitazone.
Celecoxib	Celecoxib Celecoxib may decrease the antihypertensive activities of Carvedilol.
Rosiglitazone	Rosiglitazone The therapeutic efficacy of Carvedilol can be increased when used in combination with Rosiglitazone.
Tolterodine	Tolterodine The metabolism of Carvedilol can be decreased when combined with Tolterodine.
Thalidomide	Thalidomide The risk or severity of adverse effects can be increased when Thalidomide is combined with Carvedilol.
Balsalazide	Balsalazide Balsalazide may decrease the antihypertensive activities of Carvedilol.
Nateglinide	Nateglinide The therapeutic efficacy of Carvedilol can be increased when used in combination with Nateglinide.
Galantamine	Galantamine Galantamine may increase the bradycardic activities of Carvedilol.
Rabeprazole	Rabeprazole The metabolism of Carvedilol can be decreased when combined with Rabeprazole.
Terbinafine	Terbinafine The metabolism of Carvedilol can be decreased when combined with Terbinafine.